Skip to main content
SpringerLink
Log in

Salvagetherapie bei rezidivierter ALL

HSZT eher möglich nach Therapie mit Antikörper-Wirkstoff-Konjugat

  • Info Pharm
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. freie Journalistin, Dresden, Germany

    Sabrina Kempe

Authors
  1. Sabrina Kempe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabrina Kempe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kempe, S. HSZT eher möglich nach Therapie mit Antikörper-Wirkstoff-Konjugat. Info Onkol. 22, 80 (2019). https://doi.org/10.1007/s15004-019-7209-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-019-7209-2

Search

Navigation